RVL Pharmaceuticals plc Total Liabilities
RVL Pharmaceuticals plc had Total Liabilities of $69.08 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-08-14
- 2023-06-30: Liabilities $69.08M.
- 2023-03-31: Liabilities $71.11M.
- 2022-12-31: Liabilities $77.42M.
- 2022-09-30: Liabilities $86.81M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2023-06-30 | $69.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $71.11M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $77.42M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $86.81M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $66.32M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $74.83M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $67.94M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $54.80M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $266.56M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $269.97M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $277.09M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $276.56M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $331.79M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $331.39M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $348.55M 8-K · filed 2021-09-08 | |
| 2019-09-30 | $352.48M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $388.99M 10-Q · filed 2020-08-11 | $385.92M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $397.55M 10-Q · filed 2020-05-12 | $394.91M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $411.78M 10-K · filed 2020-03-19 | $409.38M 10-K · filed 2019-03-28 |
| 2018-09-30 | $464.14M 10-Q · filed 2019-11-14 | $439.97M 10-Q · filed 2018-11-08 |
| 2017-12-31 | $485.87M 8-K · filed 2019-12-20 | $466.43M 10-Q · filed 2018-11-08 |